Antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma

• Cyrille Hulin,
• Meral Beksac,
• Hugh J. Goodman,
• Ivan Spicka,
• Adrian Alegre,
• Miles Prince,
• Frank Campana,
• Greg Finn,
• Solenn Le-Guennec,
• Sandrine Macé,
• Stéphane Muccio,
• Alexandra Tavernier,
• Marie-Claude Rouchon,
• Paul G. Richardson

Affiliations

Cyrille Hulin

Department of Hematology, Hospital De Haut Leveque, University Hospital

Meral Beksac

Waikato Hospital

Hugh J. Goodman

First Faculty of Medicine, Charles University and General Hospital, First Department of Medicine, Department of Hematology

Ivan Spicka

Hematology Service, University Hospital La Princesa

Adrian Alegre

University of Melbourne, Epworth Healthcare

Miles Prince

Sanofi

Frank Campana

Sanofi Oncology

Greg Finn

Sanofi Oncology

Solenn Le-Guennec

Sanofi R&D

Sandrine Macé

Sanofi R&D

Stéphane Muccio

Sanofi R&D

Alexandra Tavernier

Sanofi R&D

Marie-Claude Rouchon

Sanofi R&D

Paul G. Richardson

Sanofi